Five of the nine studies reported various adverse events associated with SGLT2 inhibitor use, including DKA, sepsis, urinary tract infection, genital infection, arrhythmia, hypoglycemia, amputation, and fournier’s gangrene. The gene discussed is SLC5A2; the disease is Sepsis.